Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Journal of Proteome Research
|
December 12, 2022
CPPA: A Web Tool for Exploring Proteomic and Phosphoproteomic Data in Cancer
Guo-Sheng Hu, Zao-Zao Zheng, Yao-Hui He, et al.
Molecular & Cellular Proteomics : MCP
|
January 30, 2025
Integrated Analysis of Proteome and Transcriptome Profiling Reveals Pan-Cancer-Associated Pathways and Molecular Biomarkers
Guo-Sheng Hu, Zao-Zao Zheng, Yao-Hui He, et al.
Science Bulletin
|
October 19, 2025
Nuclear receptor ESRRA promotes ERα-positive breast cancer through dual action on super enhancers and promoters to regulate gene transcriptional programs
Zao-Zao Zheng, Lu Chen, Guo-Sheng Hu, et al.
Pharmacological Research
|
January 18, 2026
A CARM1-targeted therapeutic peptide suppresses breast cancer progression both in vitro and in vivo
Bing-Ling Peng, Jun Hong, Zi-Rui Wang, et al.
Journal of Medicinal Chemistry
|
April 3, 2024
Peptide Inhibitor Targeting the Extraterminal Domain in BRD4 Potently Suppresses Breast Cancer Both <i>In Vitro</i> and <i>In Vivo</i>
Qi-Xuan Huang, Da-Meng Fan, Zao-Zao Zheng, et al.
Clinical & Translational Immunology
|
May 7, 2020
EGFR-targeted CAR-T cells are potent and specific in suppressing triple-negative breast cancer both <i>in vitro</i> and <i>in vivo</i>
Lin Xia, Zao-Zao Zheng, Jun-Yi Liu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
May 31, 2021
BRD4 inhibition boosts the therapeutic effects of epidermal growth factor receptor-targeted chimeric antigen receptor T cells in glioblastoma
Lin Xia, Jun-Yi Liu, Zao-Zao Zheng, et al.
Nucleic Acids Research
|
September 20, 2022
Super-enhancer-controlled positive feedback loop BRD4/ERα-RET-ERα promotes ERα-positive breast cancer
Zao-Zao Zheng, Lin Xia, Guo-Sheng Hu, et al.
Cellular & Molecular Immunology
|
March 2, 2023
A SARS-CoV-2-specific CAR-T-cell model identifies felodipine, fasudil, imatinib, and caspofungin as potential treatments for lethal COVID-19
Lin Xia, Lun-Zhi Yuan, Ya-Hong Hu, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Journal of Proteome Research
|
December 12, 2022
CPPA: A Web Tool for Exploring Proteomic and Phosphoproteomic Data in Cancer
Guo-Sheng Hu, Zao-Zao Zheng, Yao-Hui He, et al.
Molecular & Cellular Proteomics : MCP
|
January 30, 2025
Integrated Analysis of Proteome and Transcriptome Profiling Reveals Pan-Cancer-Associated Pathways and Molecular Biomarkers
Guo-Sheng Hu, Zao-Zao Zheng, Yao-Hui He, et al.
Science Bulletin
|
October 19, 2025
Nuclear receptor ESRRA promotes ERα-positive breast cancer through dual action on super enhancers and promoters to regulate gene transcriptional programs
Zao-Zao Zheng, Lu Chen, Guo-Sheng Hu, et al.
Pharmacological Research
|
January 18, 2026
A CARM1-targeted therapeutic peptide suppresses breast cancer progression both in vitro and in vivo
Bing-Ling Peng, Jun Hong, Zi-Rui Wang, et al.
Journal of Medicinal Chemistry
|
April 3, 2024
Peptide Inhibitor Targeting the Extraterminal Domain in BRD4 Potently Suppresses Breast Cancer Both <i>In Vitro</i> and <i>In Vivo</i>
Qi-Xuan Huang, Da-Meng Fan, Zao-Zao Zheng, et al.
Clinical & Translational Immunology
|
May 7, 2020
EGFR-targeted CAR-T cells are potent and specific in suppressing triple-negative breast cancer both <i>in vitro</i> and <i>in vivo</i>
Lin Xia, Zao-Zao Zheng, Jun-Yi Liu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
May 31, 2021
BRD4 inhibition boosts the therapeutic effects of epidermal growth factor receptor-targeted chimeric antigen receptor T cells in glioblastoma
Lin Xia, Jun-Yi Liu, Zao-Zao Zheng, et al.
Nucleic Acids Research
|
September 20, 2022
Super-enhancer-controlled positive feedback loop BRD4/ERα-RET-ERα promotes ERα-positive breast cancer
Zao-Zao Zheng, Lin Xia, Guo-Sheng Hu, et al.
Cellular & Molecular Immunology
|
March 2, 2023
A SARS-CoV-2-specific CAR-T-cell model identifies felodipine, fasudil, imatinib, and caspofungin as potential treatments for lethal COVID-19
Lin Xia, Lun-Zhi Yuan, Ya-Hong Hu, et al.
Page
of 1